Agenus reports AI analysis shows improved response rates for cancer treatment May 21, 2026 05:00PM
MiNK shares new data on agenT-797 cell therapy at ATS conference May 20, 2026 11:07AM
MiNK therapeutics starts randomized phase 2 trial for lung injury therapy May 15, 2026 07:31AM
MiNK Therapeutics shows dual immune responses from single cell therapy May 12, 2026 07:37AM
H.C. Wainwright Reiterates Buy Rating on MiNK Therapeutics (INKT) Apr 23, 2026 07:12AM


Mar 31, 2026 08:13AM MiNK Therapeutics (INKT) Misses Q4 EPS by 56c
Mar 10, 2026 05:59AM MiNK Therapeutics partners with C-Further for pediatric cancer therapy
Nov 14, 2025 07:53AM MiNK Therapeutics (INKT) Misses Q3 EPS by 65c
Nov 7, 2025 05:00PM MiNK Therapeutics (INKT) files $150M mixed shelf
Nov 7, 2025 09:01AM MiNK reports survival data for cancer cell therapy at medical meeting
Aug 15, 2025 06:05AM H.C. Wainwright Upgrades MiNK Therapeutics (INKT) to Buy
Aug 14, 2025 07:54AM MiNK Therapeutics (INKT) Misses Q2 EPS by 106c
Jul 15, 2025 10:33AM H.C. Wainwright Downgrades MiNK Therapeutics (INKT) to Neutral
Jul 15, 2025 08:27AM MiNK Therapeutics publishes research on iNKT cell therapy platform
Jul 14, 2025 07:22AM William Blair Downgrades MiNK Therapeutics (INKT) to Market Perform
Jul 14, 2025 07:08AM H.C. Wainwright Reiterates Buy Rating on MiNK Therapeutics (INKT)
Jul 11, 2025 10:46AM Agenus (AGEN) Trades Higher in Sympathy with MiNK Therapeutics (INKT)
Jul 11, 2025 07:30AM MiNK Therapeutics reports complete remission in testicular cancer patient
Jun 2, 2025 09:29AM MiNK Therapeutics (INKT) Awarded NIAID Grant to Advance Allo-iNKT Cell Therapy for Prevention of GvHD in Stem Cell Transplant Patients
May 15, 2025 04:43PM MiNK Therapeutics, Inc. (INKT) Misses Q1 EPS by 64c
Mar 18, 2025 04:05PM MiNK Therapeutics, Inc. (INKT) Misses Q4 EPS by 54c
Feb 25, 2025 06:44AM MiNK Therapeutics (INKT) PT Raised to $35 at H.C. Wainwright
Feb 20, 2025 07:30AM MiNK Therapeutics (INKT) Regains Nasdaq Compliance
Feb 12, 2025 01:03PM MiNK Therapeutics (INKT) to Present Updated Data from Phase 2 Study Testing AgenT-797 in Gastric Cancer at AACR IO Annual Meeting
Jan 23, 2025 02:13PM MiNK Therapeutics (INKT) Targets Immune Reconstitution to Combat Advanced Gastroesophageal Cancers with Novel Combination of Allo-iNKTs plus BOT/BAL at ASCO GI
Nov 15, 2024 07:21AM MiNK Therapeutics (INKT) PT Lowered to $4 at Baird
Oct 18, 2024 04:12PM MiNK Therapeutics (INKT) Announces Transition of Chief Scientific Officer
Oct 9, 2024 06:56AM H.C. Wainwright Reiterates Buy Rating on MiNK Therapeutics (INKT)
Aug 13, 2024 04:37PM MiNK Therapeutics (INKT) Files for 4.64M Share Offering by Selling Stockholders
Aug 13, 2024 07:06AM MiNK Therapeutics, Inc. (INKT) Tops Q2 EPS by 3c
Jul 31, 2024 07:31AM MiNK Therapeutics (INKT) Regains Nasdaq Compliance